<p>Praxis Investment Management Inc. 在最近向證券交易委員會提交的 13F 表格中表示，在第二季度將其在坎貝爾公司（NASDAQ:CPB - 免費報告）的股份增加了 123.2%。該基金在此期間購買了額外的 8,280 股後，持有該公司 15,000 股股票。根據其最近的 SEC 文件，Praxis Investment Management Inc. 在坎貝爾的持股價值為 460,000 美元。</p>
<ul>
<li>接近 52 周低點，這 3 只中型股值得關注</li>
</ul>
<p>其他對沖基金也調整了對該公司的持股。Ameritas Advisory Services LLC 在第二季度購買了價值 25,000 美元的坎貝爾新股份。Manchester Capital Management LLC 在第一季度將其在坎貝爾的持股增加了 923.2%。Manchester Capital Management LLC 現在擁有 706 股該公司的股票，價值 28,000 美元，此前在上個季度購買了額外的 637 股。ORG Partners LLC 在第二季度將其在坎貝爾的持股增加了 77.3%。ORG Partners LLC 現在擁有 906 股該公司的股票，價值 29,000 美元，此前在上個季度購買了額外的 395 股。Geneos Wealth Management Inc. 在第一季度將其在坎貝爾的持股增加了 333.3%。Geneos Wealth Management Inc. 現在擁有 975 股該公司的股票，價值 39,000 美元，此前在上個季度購買了額外的 750 股。最後，Banque Cantonale Vaudoise 在第一季度購買了價值約 47,000 美元的坎貝爾新股份。52.35% 的股票由對沖基金和其他機構投資者持有。</p>
<h2>坎貝爾的價格表現</h2>
<p>CPB 的股票在週五開盤價為 30.86 美元。該公司的市值為 91.9 億美元，市盈率為 15.43，市盈增長比率為 10.72，貝塔係數為 0.02。該公司的 50 日移動平均價格為 32.23 美元，200 日移動平均價格為 33.42 美元。該公司的債務與股本比率為 1.56，速動比率為 0.28，流動比率為 0.77。坎貝爾公司的 12 個月低點為 29.39 美元，12 個月高點為 48.68 美元。</p>
<ul>
<li>3 只股票呈現出世代購買機會</li>
</ul>
<p>坎貝爾（NASDAQ:CPB - 獲取免費報告）最近在 9 月 3 日星期三發佈了季度財報。該公司報告本季度每股收益為 0.62 美元，超出市場共識預期的 0.57 美元，超出 0.05 美元。該公司本季度的收入為 23.2 億美元，而分析師預期為 23.3 億美元。坎貝爾的淨利潤率為 5.87%，股本回報率為 22.95%。該公司的季度收入同比增長 1.2%。去年同期，該公司每股收益為 3.08 美元。坎貝爾已將其 2026 財年的指引設定為每股收益 2.400-2.550。整體而言，研究分析師預計坎貝爾公司本財年將發佈 3.15 的每股收益。</p>
<h2>坎貝爾的股息公告</h2>
<p>該公司最近還披露了季度股息，將於 11 月 3 日星期一支付。10 月 2 日星期四的登記股東將獲得每股 0.39 美元的股息。該股息的除息日為 10 月 2 日星期四。這相當於每年 1.56 美元的股息，股息收益率為 5.1%。坎貝爾的股息支付比率目前為 78.00%。</p>
<h2>華爾街分析師的看法</h2>
<ul>
<li>坎貝爾的股票在 2025 年可能帶來豐厚回報的 4 個理由</li>
</ul>
<p>幾位股票研究分析師最近對該公司發佈了報告。富國銀行將坎貝爾的目標價從 32.00 美元上調至 34.00 美元，並在 9 月 25 日星期四的研究報告中給予該股 “持平” 評級。Stifel Nicolaus 將坎貝爾的目標價從 38.00 美元下調至 34.00 美元，並在 7 月 29 日星期二的研究報告中對該公司給予 “持有” 評級。TD Cowen 將坎貝爾的目標價從 29.00 美元上調至 31.00 美元，並在 9 月 4 日星期四的研究報告中給予該股 “持有” 評級。摩根大通在 8 月 20 日星期三的研究報告中開始覆蓋坎貝爾。他們給予該公司 “中性” 評級，目標價為 33.00 美元。最後，摩根士丹利將坎貝爾的目標價從 32.00 美元上調至 33.00 美元，並在 9 月 5 日星期五的研究報告中給予該股 “持平” 評級。三位股票研究分析師對該股給予買入評級，十五位給予持有評級，五位給予賣出評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “減持”，共識目標價為 34.82 美元。</p>
<p><strong>查看我們關於坎貝爾的最新研究報告</strong></p>
<h2>坎貝爾的公司簡介</h2>
<p>（免費報告）</p>
<p>坎貝爾公司，前身為坎貝爾湯公司，及其子公司在美國和國際上製造和銷售食品和飲料產品。該公司通過餐飲和飲料以及零食兩個部門運營。餐飲和飲料部門從事美國和加拿大的零售和餐飲服務業務。</p>
<h2>精選文章</h2>
<ul>
<li>我們更看好的五隻股票超過坎貝爾</li>
<li>股票回購是什麼？投資者的全面指南</li>
<li>強生的併購戰略才是投資者真正關注的故事</li>
<li>什麼是稀釋每股收益（Diluted EPS）？</li>
<li>特斯拉：一些分析師預測將下跌 30%——是時候恐慌了嗎？</li>
<li>零售股票投資，解釋</li>
<li>對沖基金對美元的態度轉變——這 3 只股票的買入信號？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1BC?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1BC"/></p>
<p><em>此即時新聞提醒是由敍事科學技術和 MarketBeat 的金融數據生成的，旨在為讀者提供最快和最準確的報道。此故事在發佈前經過了 MarketBeat 編輯團隊的審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
<h2>你現在應該投資 1000 美元在康寶濃湯嗎？</h2>
<p>在考慮康寶濃湯之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而康寶濃湯並不在名單上。</p>
<p>雖然康寶濃湯目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

康寶濃湯

<p>Praxis Investment Management Inc. 在第二季度將其在康寶濃湯公司（NASDAQ:CPB）的持股增加了 123.2%，目前擁有 15,000 股，價值 46 萬美元。其他對沖基金也調整了他們的持股。康寶濃湯報告了第三季度每股收益為 0.62 美元，超出預期，收入為 23.2 億美元。該公司宣佈季度股息為每股 0.39 美元，收益率為 5.1%。分析師對該股票的評級不一，目標價格範圍在 29 美元到 38 美元之間</p>

<p>Praxis Investment Management Inc. grew its stake in shares of The Campbell's Company (NASDAQ:CPB - Free Report) by 123.2% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The fund owned 15,000 shares of the company's stock after purchasing an additional 8,280 shares during the period. Praxis Investment Management Inc.'s holdings in Campbell's were worth $460,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Praxis Investment Management Inc. 在最近向證券交易委員會提交的 13F 表格中表示，在第二季度將其在坎貝爾公司（NASDAQ:CPB - 免費報告）的股份增加了 123.2%。該基金在此期間購買了額外的 8,280 股後，持有該公司 15,000 股股票。根據其最近的 SEC 文件，Praxis Investment Management Inc. 在坎貝爾的持股價值為 460,000 美元。</p>
</div><ul>
<li>Near 52-Week Lows, These 3 Mid-Cap Stocks Are Worth a Look</li>
</ul>
<div class="lb-trans"><ul>
<li>接近 52 周低點，這 3 只中型股值得關注</li>
</ul>
</div><p>Other hedge funds have also modified their holdings of the company. Ameritas Advisory Services LLC purchased a new stake in shares of Campbell's during the second quarter valued at $25,000. Manchester Capital Management LLC lifted its holdings in shares of Campbell's by 923.2% during the first quarter. Manchester Capital Management LLC now owns 706 shares of the company's stock valued at $28,000 after purchasing an additional 637 shares during the last quarter. ORG Partners LLC lifted its holdings in shares of Campbell's by 77.3% during the second quarter. ORG Partners LLC now owns 906 shares of the company's stock valued at $29,000 after purchasing an additional 395 shares during the last quarter. Geneos Wealth Management Inc. lifted its holdings in shares of Campbell's by 333.3% during the first quarter. Geneos Wealth Management Inc. now owns 975 shares of the company's stock valued at $39,000 after purchasing an additional 750 shares during the last quarter. Finally, Banque Cantonale Vaudoise purchased a new stake in Campbell's in the 1st quarter worth about $47,000. 52.35% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他對沖基金也調整了對該公司的持股。Ameritas Advisory Services LLC 在第二季度購買了價值 25,000 美元的坎貝爾新股份。Manchester Capital Management LLC 在第一季度將其在坎貝爾的持股增加了 923.2%。Manchester Capital Management LLC 現在擁有 706 股該公司的股票，價值 28,000 美元，此前在上個季度購買了額外的 637 股。ORG Partners LLC 在第二季度將其在坎貝爾的持股增加了 77.3%。ORG Partners LLC 現在擁有 906 股該公司的股票，價值 29,000 美元，此前在上個季度購買了額外的 395 股。Geneos Wealth Management Inc. 在第一季度將其在坎貝爾的持股增加了 333.3%。Geneos Wealth Management Inc. 現在擁有 975 股該公司的股票，價值 39,000 美元，此前在上個季度購買了額外的 750 股。最後，Banque Cantonale Vaudoise 在第一季度購買了價值約 47,000 美元的坎貝爾新股份。52.35% 的股票由對沖基金和其他機構投資者持有。</p>
</div><h2>Campbell's Price Performance</h2>
<div class="lb-trans"><h2>坎貝爾的價格表現</h2>
</div><p>Shares of CPB opened at $30.86 on Friday. The firm has a market cap of $9.19 billion, a PE ratio of 15.43, a PEG ratio of 10.72 and a beta of 0.02. The firm's 50 day moving average price is $32.23 and its 200 day moving average price is $33.42. The company has a debt-to-equity ratio of 1.56, a quick ratio of 0.28 and a current ratio of 0.77. The Campbell's Company has a twelve month low of $29.39 and a twelve month high of $48.68.</p>
<div class="lb-trans"><p>CPB 的股票在週五開盤價為 30.86 美元。該公司的市值為 91.9 億美元，市盈率為 15.43，市盈增長比率為 10.72，貝塔係數為 0.02。該公司的 50 日移動平均價格為 32.23 美元，200 日移動平均價格為 33.42 美元。該公司的債務與股本比率為 1.56，速動比率為 0.28，流動比率為 0.77。坎貝爾公司的 12 個月低點為 29.39 美元，12 個月高點為 48.68 美元。</p>
</div><ul>
<li>3 Stocks Presenting Generational Buying Opportunities</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只股票呈現出世代購買機會</li>
</ul>
</div><p>Campbell's (NASDAQ:CPB - Get Free Report) last issued its quarterly earnings data on Wednesday, September 3rd. The company reported $0.62 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.05. The firm had revenue of $2.32 billion for the quarter, compared to analyst estimates of $2.33 billion. Campbell's had a net margin of 5.87% and a return on equity of 22.95%. The company's revenue for the quarter was up 1.2% on a year-over-year basis. During the same quarter last year, the firm earned $3.08 earnings per share. Campbell's has set its FY 2026 guidance at 2.400-2.550 EPS. As a group, research analysts expect that The Campbell's Company will post 3.15 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>坎貝爾（NASDAQ:CPB - 獲取免費報告）最近在 9 月 3 日星期三發佈了季度財報。該公司報告本季度每股收益為 0.62 美元，超出市場共識預期的 0.57 美元，超出 0.05 美元。該公司本季度的收入為 23.2 億美元，而分析師預期為 23.3 億美元。坎貝爾的淨利潤率為 5.87%，股本回報率為 22.95%。該公司的季度收入同比增長 1.2%。去年同期，該公司每股收益為 3.08 美元。坎貝爾已將其 2026 財年的指引設定為每股收益 2.400-2.550。整體而言，研究分析師預計坎貝爾公司本財年將發佈 3.15 的每股收益。</p>
</div><h2>Campbell's Dividend Announcement</h2>
<div class="lb-trans"><h2>坎貝爾的股息公告</h2>
</div><p>The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 2nd will be issued a dividend of $0.39 per share. The ex-dividend date of this dividend is Thursday, October 2nd. This represents a $1.56 dividend on an annualized basis and a dividend yield of 5.1%. Campbell's's dividend payout ratio is currently 78.00%.</p>
<div class="lb-trans"><p>該公司最近還披露了季度股息，將於 11 月 3 日星期一支付。10 月 2 日星期四的登記股東將獲得每股 0.39 美元的股息。該股息的除息日為 10 月 2 日星期四。這相當於每年 1.56 美元的股息，股息收益率為 5.1%。坎貝爾的股息支付比率目前為 78.00%。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>華爾街分析師的看法</h2>
</div><ul>
<li>4 Reasons Campbell’s Stock Could Serve Up Big Returns in 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>坎貝爾的股票在 2025 年可能帶來豐厚回報的 4 個理由</li>
</ul>
</div><p>Several equities research analysts recently issued reports on the company. Wells Fargo &amp; Company increased their price objective on Campbell's from $32.00 to $34.00 and gave the stock an &#34;equal weight&#34; rating in a research note on Thursday, September 25th. Stifel Nicolaus reduced their price objective on Campbell's from $38.00 to $34.00 and set a &#34;hold&#34; rating for the company in a research note on Tuesday, July 29th. TD Cowen increased their price objective on Campbell's from $29.00 to $31.00 and gave the stock a &#34;hold&#34; rating in a research note on Thursday, September 4th. JPMorgan Chase &amp; Co. assumed coverage on Campbell's in a research note on Wednesday, August 20th. They issued a &#34;neutral&#34; rating and a $33.00 price objective for the company. Finally, Morgan Stanley increased their price objective on Campbell's from $32.00 to $33.00 and gave the stock an &#34;equal weight&#34; rating in a research note on Friday, September 5th. Three equities research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of &#34;Reduce&#34; and a consensus target price of $34.82.</p>
<div class="lb-trans"><p>幾位股票研究分析師最近對該公司發佈了報告。富國銀行將坎貝爾的目標價從 32.00 美元上調至 34.00 美元，並在 9 月 25 日星期四的研究報告中給予該股 “持平” 評級。Stifel Nicolaus 將坎貝爾的目標價從 38.00 美元下調至 34.00 美元，並在 7 月 29 日星期二的研究報告中對該公司給予 “持有” 評級。TD Cowen 將坎貝爾的目標價從 29.00 美元上調至 31.00 美元，並在 9 月 4 日星期四的研究報告中給予該股 “持有” 評級。摩根大通在 8 月 20 日星期三的研究報告中開始覆蓋坎貝爾。他們給予該公司 “中性” 評級，目標價為 33.00 美元。最後，摩根士丹利將坎貝爾的目標價從 32.00 美元上調至 33.00 美元，並在 9 月 5 日星期五的研究報告中給予該股 “持平” 評級。三位股票研究分析師對該股給予買入評級，十五位給予持有評級，五位給予賣出評級。根據 MarketBeat.com 的數據，該公司目前的共識評級為 “減持”，共識目標價為 34.82 美元。</p>
</div><p><strong>Check Out Our Latest Research Report on Campbell's</strong></p>
<div class="lb-trans"><p><strong>查看我們關於坎貝爾的最新研究報告</strong></p>
</div><h2>Campbell's Profile</h2>
<div class="lb-trans"><h2>坎貝爾的公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>The Campbell's Company, formerly known as Campbell Soup Company, together with its subsidiaries, manufactures and markets food and beverage products in the United States and internationally. The company operates through Meals &amp; Beverages and Snacks segments. The Meals &amp; Beverages segment engages in the retail and foodservice businesses in the United States and Canada.</p>
<div class="lb-trans"><p>坎貝爾公司，前身為坎貝爾湯公司，及其子公司在美國和國際上製造和銷售食品和飲料產品。該公司通過餐飲和飲料以及零食兩個部門運營。餐飲和飲料部門從事美國和加拿大的零售和餐飲服務業務。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Campbell's</li>
<li>What is a buyback in stocks? A comprehensive guide for investors</li>
<li>Johnson &amp; Johnson's M&amp;A Strategy Is the Real Story for Investors</li>
<li>What is diluted earnings per share (Diluted EPS)?</li>
<li>Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?</li>
<li>Retail Stocks Investing, Explained</li>
<li>Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過坎貝爾</li>
<li>股票回購是什麼？投資者的全面指南</li>
<li>強生的併購戰略才是投資者真正關注的故事</li>
<li>什麼是稀釋每股收益（Diluted EPS）？</li>
<li>特斯拉：一些分析師預測將下跌 30%——是時候恐慌了嗎？</li>
<li>零售股票投資，解釋</li>
<li>對沖基金對美元的態度轉變——這 3 只股票的買入信號？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1BC" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=CPB"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒是由敍事科學技術和 MarketBeat 的金融數據生成的，旨在為讀者提供最快和最準確的報道。此故事在發佈前經過了 MarketBeat 編輯團隊的審核。如對該故事有任何問題或意見，請發送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Campbell's Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在康寶濃湯嗎？</h2>
</div><p>Before you consider Campbell's, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮康寶濃湯之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Campbell's wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而康寶濃湯並不在名單上。</p>
</div><p>While Campbell's currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然康寶濃湯目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Praxis 投資管理公司增持了康寶濃湯公司 $CPB 的持股